$98.05
-1.47-1.48%
At close: -
$98.99
0.940.96%
After Hours: Dec 20, 7:59 PM EDT
Merck & Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Merck & Co using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $1.57 | $1.51 | 3.97 % |
Jun 2024 | 2024-07-30 | $2.28 | $2.15 | 6.05 % |
Mar 2024 | 2024-04-25 | $2.07 | $1.87 | 10.7 % |
Dec 2023 | 2024-02-01 | $0.03 | $-0.11 | 127.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-31 | $16.66B | $16.47B | 1.14 % |
Jun 2024 | 2024-07-30 | $16.11B | $15.84B | 1.72 % |
Mar 2024 | 2024-04-25 | $15.78B | $15.20B | 3.78 % |
Dec 2023 | 2024-02-01 | $14.63B | $14.50B | 0.91 % |
Merck & Co (MRK) is scheduled to report earnings on February 4, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
The Actual EPS was $1.57, which beat the estimate of $1.51.
The Actual Revenue was $16.7B, which beat the estimate of $16.5B.
Browse earnings estimates, EPS, and revenue on all stocks.